From respiratory cultures to empirical treatment: Integrating local resistance data, colonization risk, and patient-level factors in hospital-acquired pneumonia

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 34

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJPM-5-3_006

تاریخ نمایه سازی: 21 آبان 1405

چکیده مقاله:

Hospital-acquired pneumonia (HAP) remains a leading cause of nosocomial morbidity and mortality, particularly among mechanically ventilated and critically ill patients, and delays in adequate empirical antimicrobial coverage are independently associated with worsened outcomes. Because culture-based pathogen identification and susceptibility testing require time, clinicians must bridge the resulting uncertainty by integrating local epidemiological data with patient-specific risk assessment.This narrative review examines the interplay among respiratory culture results, local resistance data, colonization dynamics, and patient-level variables in shaping empirical therapy for HAP. Respiratory cultures from endotracheal aspirates or bronchoalveolar lavage remain the microbiological cornerstone of diagnosis and de-escalation, while emerging molecular diagnostics promise to shorten the empirical window. Cumulative antibiograms provide quantitative susceptibility estimates but report organism–drug pairs rather than syndrome-level coverage; weighted-incidence syndromic combination antibiograms (WISCA) address this limitation by incorporating pathogen incidence and combination susceptibility, and have been validated in ventilator-associated pneumonia and other syndromes. Colonization with multidrug-resistant organisms, prior culture results, clinical frailty, and immunocompromised status further modify the probability of resistant pathogens. Inappropriate empirical therapy is consistently associated with excess mortality, whereas guideline-concordant, microbiologically appropriate treatment improves outcomes in multidrug-resistant infections. Robust decision algorithms require deliberate integration of epidemiological, microbiological, and clinical data streams, supported by standardized reporting and bias assessment. Resource-limited and high-resistance settings face amplified challenges, yet cost-effective microbiology services and locally adapted antibiograms remain feasible and essential. Sustained investment in laboratory capacity, clinician education, rapid diagnostics, WISCA adoption, and hospital-wide stewardship interventions offers the most practical pathway to narrowing the gap between respiratory culture results and timely, adequate empirical treatment while minimizing selective pressure for further resistance.

کلیدواژه ها:

نویسندگان

- -

Department of Periodontics, School of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran

- -

Department of Infectious Disease, School of Medicine, Shahid Beheshti Hospital, Kashan University of Medical Sciences, Kashan, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, ...
  • Kollef MH. Ventilator-associated pneumonia: a multivariate analysis. JAMA. ۱۹۹۳;۲۷۰(۱۶):۱۹۶۵-۱۹۷۰. doi:۱۰.۱۰۰۱/jama.۱۹۹۳.۰۳۵۱۰۱۶۰۰۸۳۰۳۴ ...
  • Chastre J, Fagon JY, Soler P, Bornet M, Domart Y, ...
  • Papazian L, Klompas M, Luyt CE. Ventilator-associated pneumonia in adults: ...
  • Leroy O, Jaffré S, D'Escrivan T, Devos P, Georges H, ...
  • Heitz M, Levrat A, Lazarevic V, Barraud O, Bland S, ...
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility ...
  • Timsit JF, Soubirou JF, Voiriot G, Chemam S, Neuville M, ...
  • O'Brien TF, Stelling JM. WHONET: an information system for monitoring ...
  • Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar ...
  • doi:۱۰.۳۳۹۰/jcm۱۳۲۰۶۲۱۹ PMid:۳۹۴۵۸۱۶۹ PMCid:PMC۱۱۵۰۸۲۹ ...
  • Briseno-Ramírez J, Gómez-Quiroz A, Avila-Cardenas BB, De Arcos-Jiménez JC, Perales-Guerrero ...
  • Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone ...
  • Detsis M, Karanika S, Mylonakis E. ICU acquisition rate, risk ...
  • World Health Organization. Global priority list of antibiotic-resistant bacteria to ...
  • Nordmann P, Naas T, Poirel L. Global spread of carbapenemase- ...
  • Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin ...
  • Bush K, Bradford PA. Epidemiology of beta-lactamase-producing pathogens. Clin Microbiol ...
  • Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global ...
  • Kollef MH. Appropriate empiric antibacterial therapy for nosocomial infections: getting ...
  • Kollef MH. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the ...
  • Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, ...
  • Paul M, Kariv G, Goldberg E, Raskin M, Shaked H, ...
  • Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, ...
  • Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome ...
  • Allel K, Peters A, Furuya-Kanamori L, Spencer-Sandino M, Pitchforth E, ...
  • Murphy CN, Fowler R, Balada-Llasat JM, Carroll A, Stone H, ...
  • Hill JT, Tran KD, Barton KL, Labreche MJ, Sharp SE. ...
  • Marquette CH, Georges H, Wallet F, Ramon P, Saulnier F, ...
  • Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, ...
  • نمایش کامل مراجع